Faculty & Research
Insights into groundbreaking faculty research, innovative projects, and academic thought leadership across Harvard’s schools and institutes.
Omnibus Omicron Intelligence
Harvard Medical School experts on viral evolution, vaccines, the immune system—and what’s next
by Jonathan Shaw
Epstein-Barr Virus Implicated as Cause of Multiple Sclerosis
Harvard researchers uncover powerful association between EBV and MS, raising hopes for prevention or a cure.
by Jonathan Shaw
Thank the Rich for Low Rates?
High savings rates among the wealthiest U.S. earners may represent a macroeconomic risk
by Jonathan Shaw
Will Cities Survive Another Pandemic?
Inequities threaten the long-term health of cities
by Daniel Oberhaus
Your Brain on Exercise
The hormone irisin, promising as a therapeutic against Alzheimer’s and dementia, is responsible for the cognitive benefits of exercise.
by Jonathan Shaw
Both Sides Now
Tomiko Brown-Nagin’s bifocal view of the civil-rights movement
by Lincoln Caplan
Chan Zuckerberg Commits $500 Million to Harvard Neuroscience and AI Institute
A 15-year investment in biomedical and applied science research
by Jonathan Shaw
Against Delta, Moderna Edges Pfizer, but Omicron Looms
A head-to-head comparison in 440,000 vaccinated veterans finds Moderna’s vaccine is slightly more effective than Pfizer’s at preventing a range of COVID-19 outcomes.
by Jonathan Shaw
A Bumper Crop in the National Academy of Medicine
Newly elected members include a dozen Harvard faculty affiliates.
by John S. Rosenberg
Can Slime Molds Think?
A seemingly primitive creature’s complex ability to detect mass from a distance.
by Nancy Walecki